scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Marshall Lightowlers | Q6773683 |
Steven G Reed | Q89520964 | ||
William A. Petri | Q27663335 | ||
Alex Loukas | Q30513842 | ||
Jesus G Valenzuela | Q56775666 | ||
Xiaoti Guo | Q66018086 | ||
P2093 | author name string | Shaden Kamhawi | |
Jeffrey M Bethony | |||
Rhea N Cole | |||
P2860 | cites work | Entamoeba histolytica phagocytosis of human erythrocytes involves PATMK, a member of the transmembrane kinase family | Q21090527 |
Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden | Q21092296 | ||
Liver fluke induces cholangiocarcinoma | Q21092372 | ||
Hookworm-related anaemia among pregnant women: a systematic review | Q21144550 | ||
Chagas disease: an impediment in achieving the Millennium Development Goals in Latin America | Q21254563 | ||
Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs | Q21563438 | ||
The genome of the blood fluke Schistosoma mansoni | Q22122228 | ||
The Schistosoma japonicum genome reveals features of host-parasite interplay | Q22122229 | ||
The antipoverty vaccines | Q24290719 | ||
Rescuing the bottom billion through control of neglected tropical diseases | Q24290723 | ||
Biochemical characterization and vaccine potential of a heme-binding glutathione transferase from the adult hookworm Ancylostoma caninum | Q24534649 | ||
Entamoeba histolytica infection in children and protection from subsequent amebiasis | Q24537379 | ||
Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen | Q24597151 | ||
Disease and Development: Evidence from Hookworm Eradication in the American South | Q24607787 | ||
Helminth infections: the great neglected tropical diseases | Q24648324 | ||
Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine | Q24655529 | ||
Current status of vaccines for schistosomiasis | Q24657733 | ||
The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response | Q24657806 | ||
"Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor | Q24810845 | ||
Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria | Q25256957 | ||
Health education through analogies: preparation of a community for clinical trials of a vaccine against hookworm in an endemic area of Brazil | Q27306739 | ||
An annotated catalogue of salivary gland transcripts in the adult female mosquito, Aedes aegypti | Q27478018 | ||
Hyaluronidase of Bloodsucking Insects and Its Enhancing Effect on Leishmania Infection in Mice | Q27486947 | ||
SAAG-4 is a novel mosquito salivary protein that programmes host CD4+T cells to express IL-4 | Q27489884 | ||
Insight into the sialome of the Black Fly, Simulium vittatum | Q27490406 | ||
An insight into the sialome of Glossina morsitans morsitans | Q27491348 | ||
X-ray structures of Na-GST-1 and Na-GST-2 two glutathione s-transferase from the human hookworm Necator americanus | Q27646442 | ||
Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate | Q27653441 | ||
The immunology of susceptibility and resistance to Leishmania major in mice | Q34988360 | ||
Resistance of Schistosoma mansoni to praziquantel: is there a problem? | Q35021630 | ||
Progress in control of hydatidosis using vaccination--a review of formulation and delivery of the vaccine and recommendations for practical use in control programmes | Q35073501 | ||
The impact of chemotherapy on morbidity due to schistosomiasis | Q35126805 | ||
Animal models for the analysis of immune responses to leishmaniasis | Q35188674 | ||
Development of a leishmaniasis vaccine: the importance of MPL. | Q35192190 | ||
Tsetse fly saliva accelerates the onset of Trypanosoma brucei infection in a mouse model associated with a reduced host inflammatory response | Q35217499 | ||
Schistosomiasis control: keep taking the tablets. | Q35640594 | ||
Helminth parasites--masters of regulation | Q35884205 | ||
Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells | Q35947234 | ||
Sociobehavioural research methods for the introduction of vaccines in the Diseases of the Most Impoverished Programme. | Q35989214 | ||
Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? | Q36056272 | ||
Schistosomes: the road from host-parasite interactions to vaccines in clinical trials | Q36056288 | ||
Second-generation vaccines against leishmaniasis | Q36101424 | ||
Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant | Q36141819 | ||
Immunity induced by the radiation-attenuated schistosome vaccine | Q36247360 | ||
Neurocysticercosis: updated concepts about an old disease | Q36259999 | ||
Leptospirosis vaccines: past, present, and future. | Q36333300 | ||
Prevalence and incidence of Entamoeba histolytica infection in South Africa and Egypt | Q36354569 | ||
Recombinant interleukin 12 cures mice infected with Leishmania major | Q36361742 | ||
Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response | Q36361808 | ||
A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. | Q36364671 | ||
Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein | Q36369425 | ||
Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis | Q36401312 | ||
The immunomodulatory factors of arthropod saliva and the potential for these factors to serve as vaccine targets to prevent pathogen transmission | Q36423181 | ||
Drug resistance in amoebiasis. | Q36436461 | ||
New technologies for the control of human hookworm infection | Q36482272 | ||
Is it possible to develop pan-arthropod vaccines? | Q36511466 | ||
Hookworm vaccines: past, present, and future | Q36635886 | ||
Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. | Q36678092 | ||
Schistosome membrane proteins as vaccines | Q36707894 | ||
Cestode vaccines: origins, current status and future prospects. | Q36726734 | ||
Vaccines against blood-feeding nematodes of humans and livestock | Q36726742 | ||
Artemisinins for schistosomiasis and beyond. | Q36747308 | ||
The evaluation of recombinant hookworm antigens as vaccines in hamsters (Mesocricetus auratus) challenged with human hookworm, Necator americanus | Q42626863 | ||
Empowering women and improving female reproductive health through control of neglected tropical diseases | Q42630557 | ||
"Manifesto" for advancing the control and elimination of neglected tropical diseases | Q42770755 | ||
Neglected diseases and poverty in "The Other America": the greatest health disparity in the United States? | Q42868433 | ||
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis | Q42945323 | ||
The giant anteater in the room: Brazil's neglected tropical diseases problem | Q43073106 | ||
Black fly salivary gland extract inhibits proliferation and induces apoptosis in murine splenocytes | Q43096455 | ||
Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasis | Q43109540 | ||
Epidemiologic features of equine Leptospira interrogans of human significance | Q43214164 | ||
Vaccination of pigs to control human neurocysticercosis | Q43218919 | ||
Can schistosomiasis really be consigned to history without a vaccine? | Q43361070 | ||
A strategy to control transmission of Schistosoma japonicum in China | Q43367057 | ||
Continued ultrasonic follow-up of children infected with Schistosoma haematobium after treatment with praziquantel | Q43550539 | ||
Vaccine strategies against schistosomiasis: from concepts to clinical trials | Q43578478 | ||
Protective immunity in baboons vaccinated with a recombinant antigen or radiation-attenuated cercariae of Schistosoma mansoni is antibody-dependent | Q43614701 | ||
Immunoglobulins associated with passive transfer of resistance to Taenia taeniaeformis in the mouse | Q43684741 | ||
Heavy schistosomiasis associated with poor short-term memory and slower reaction times in Tanzanian schoolchildren | Q43950575 | ||
Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area. | Q43954184 | ||
The diagnosis of hookworm disease;. | Q44940555 | ||
Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia | Q45382040 | ||
Vaccination against ovine cysticercosis using a defined recombinant antigen | Q45764057 | ||
Protective immunity to Schistosoma mansoni induced in the olive baboon Papio anubis by the irradiated cercaria vaccine | Q46214496 | ||
Potential eradicability of taeniasis and cysticercosis. | Q46615605 | ||
Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis | Q46711852 | ||
Necator americanus: optimization of the golden hamster model for testing anthelmintic drugs | Q46730808 | ||
Expression of yellow jacket and wasp venom Ag5 allergens in bacteria and in yeast. | Q46767336 | ||
Proteins exposed at the adult schistosome surface revealed by biotinylation | Q46790359 | ||
Water contact observations in Kenyan communities endemic for schistosomiasis: methodology and patterns of behaviour | Q46898070 | ||
The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction | Q46919769 | ||
Helminths, allergic disorders and IgE-mediated immune responses: where do we stand? | Q34620969 | ||
The immunobiology of schistosomiasis | Q34718128 | ||
Vaccines for leishmaniasis in the fore coming 25 years. | Q34754538 | ||
Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults | Q34768601 | ||
The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine | Q34844960 | ||
New vaccines for developing countries: will it be feast or famine? | Q84444922 | ||
In vitro cultivation of Echinococcus granulosus, Taenia hydatigena, T. ovis, T. pisiformis and T. serialis from oncosphere to cystic larva | Q93698214 | ||
Nitazoxanide: an important advance in anti-parasitic therapy | Q28188892 | ||
Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm | Q28238731 | ||
Asthma and current intestinal parasite infection: systematic review and meta-analysis | Q28246448 | ||
The neglected tropical diseases: the ancient afflictions of stigma and poverty and the prospects for their control and elimination | Q28248682 | ||
A plan to defeat neglected tropical diseases | Q28269913 | ||
Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis | Q28277486 | ||
Association between genital schistosomiasis and HIV in rural Zimbabwean women | Q28296559 | ||
Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva | Q28469147 | ||
Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos | Q28743949 | ||
Neglected Diseases Amid Wealth In The United States And Europe | Q29032269 | ||
Hookworm Infection | Q29544757 | ||
Control of neglected tropical diseases | Q29547285 | ||
Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk | Q29547716 | ||
Soil-transmitted helminth infections: updating the global picture | Q29619026 | ||
Role of arthropod saliva in blood feeding: sialome and post-sialome perspectives | Q29619418 | ||
Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis | Q29619819 | ||
Hookworm Vaccines | Q30053761 | ||
The bittersweet interface of parasite and host: lectin-carbohydrate interactions during human invasion by the parasite Entamoeba histolytica | Q30309667 | ||
Association between Cryptosporidium infection and human leukocyte antigen class I and class II alleles | Q30425869 | ||
Deficient serum mannose-binding lectin levels and MBL2 polymorphisms increase the risk of single and recurrent Cryptosporidium infections in young children | Q30425921 | ||
Prospective case-control study of the association between common enteric protozoal parasites and diarrhea in Bangladesh | Q30435884 | ||
Multiplex real-time PCR assay using Scorpion probes and DNA capture for genotype-specific detection of Giardia lamblia on fecal samples | Q30436131 | ||
Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon | Q30436915 | ||
Vaccine prospects for amebiasis | Q30438347 | ||
Use of a modified informed consent process among vulnerable patients: a descriptive study | Q30479131 | ||
Ancylostoma secreted protein 2: cloning and characterization of a second member of a family of nematode secreted proteins from Ancylostoma caninum | Q30700909 | ||
Evidence for an association between hookworm infection and cognitive function in Indonesian school children | Q30732146 | ||
Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni | Q30788653 | ||
Visceral leishmaniasis in eastern Africa--current status | Q36882296 | ||
Role of sand fly saliva in human and experimental leishmaniasis: current insights | Q36884480 | ||
Neglected diseases, civil conflicts, and the right to health | Q36914039 | ||
DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo | Q36936145 | ||
Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar | Q36947786 | ||
Renewed hope for a vaccine against the intestinal adult Taenia solium. | Q36961853 | ||
Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine | Q36974519 | ||
Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies. | Q37128771 | ||
Polymorphic mucin antigens CpMuc4 and CpMuc5 are integral to Cryptosporidium parvum infection in vitro | Q37158734 | ||
Sand flies, Leishmania, and transcriptome-borne solutions | Q37162773 | ||
Can visceral leishmaniasis be eliminated from Asia? | Q37204166 | ||
Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model | Q37216479 | ||
Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection | Q37223654 | ||
Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis | Q37229920 | ||
Vaccination of dogs against Echinococcus granulosus: a means to control hydatid disease? | Q37234727 | ||
Plants as biofactories | Q37304459 | ||
An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection | Q37326963 | ||
Oral immunization with attenuated Salmonella enterica serovar Typhimurium encoding Cryptosporidium parvum Cp23 and Cp40 antigens induces a specific immune response in mice | Q37349230 | ||
Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement | Q37403491 | ||
Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni | Q37450247 | ||
Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens | Q37521740 | ||
Treatment of leprosy in India | Q37626372 | ||
Escalating the global fight against neglected tropical diseases through interventions in the Asia Pacific region | Q37771989 | ||
Potency testing for the experimental Na-GST-1 hookworm vaccine | Q37798012 | ||
Developing vaccines to combat hookworm infection and intestinal schistosomiasis | Q37800361 | ||
Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease | Q38370347 | ||
Control of human African trypanosomiasis: back to square one | Q38496534 | ||
Specific cross-protection between Schistosoma bovis and S. haematobium induced by highly irradiated infections in mice | Q38862356 | ||
In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens | Q38866692 | ||
Tsetse fly saliva biases the immune response to Th2 and induces anti-vector antibodies that are a useful tool for exposure assessment | Q38879364 | ||
Schistosomiasis vaccine:research to development | Q38905325 | ||
Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals | Q38906805 | ||
Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt | Q38916056 | ||
A new family of giardial cysteine-rich non-VSP protein genes and a novel cyst protein | Q31087387 | ||
Isolation of cDNAs encoding secreted and transmembrane proteins from Schistosoma mansoni by a signal sequence trap method | Q31139373 | ||
Willingness to be vaccinated against shigella and other forms of dysentery: a comparison of three regions in Asia | Q33222697 | ||
From transcriptome to immunome: identification of DTH inducing proteins from a Phlebotomus ariasi salivary gland cDNA library | Q33223107 | ||
Operational challenges in large clinical trials: examples and lessons learned from the gambia pneumococcal vaccine trial | Q33251907 | ||
Neglected patients with a neglected disease? A qualitative study of lymphatic filariasis | Q33308747 | ||
Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva | Q33308759 | ||
Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease | Q33328462 | ||
The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination | Q33372349 | ||
Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania | Q33450546 | ||
The introduction of new vaccines into developing countries. | Q33539104 | ||
Suppression of mRNAs encoding tegument tetraspanins from Schistosoma mansoni results in impaired tegument turnover | Q33564382 | ||
Parasites and poverty: the case of schistosomiasis | Q33615662 | ||
Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus | Q33769088 | ||
Vaccination against helminth parasites--the ultimate challenge for vaccinologists? | Q33784974 | ||
Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon | Q33799266 | ||
Mosquito feeding modulates Th1 and Th2 cytokines in flavivirus susceptible mice: an effect mimicked by injection of sialokinins, but not demonstrated in flavivirus resistant mice | Q33855321 | ||
Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE. | Q33870336 | ||
Leishmaniasis: current status of vaccine development | Q33941719 | ||
Clinical and experimental advances in treatment of visceral leishmaniasis | Q33982648 | ||
Aedes aegypti salivary gland extracts modulate anti-viral and TH1/TH2 cytokine responses to sindbis virus infection | Q33984588 | ||
Human immune responses to Schistosoma mansoni vaccine candidate antigens | Q34004360 | ||
Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease | Q34008104 | ||
Natural versus drug-induced resistance in Schistosoma mansoni infection | Q34010207 | ||
Fact or hypothesis: concomitant immunity in taeniid cestode infections. | Q34032337 | ||
Allergy, parasites, and the hygiene hypothesis | Q34124658 | ||
Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis | Q34128082 | ||
Cryptosporidiosis. | Q34130836 | ||
The public health importance of hookworm disease | Q34270014 | ||
The molecular revolution in the development of vaccines against ectoparasites | Q34438116 | ||
Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials | Q34438394 | ||
Infections and allergy - helminths, hygiene and host immune regulation | Q34456465 | ||
Hydatid disease in China | Q38955619 | ||
Homologous and heterologous protective immunity to Egyptian strains of Schistosoma mansoni and S. haematobium induced by ultraviolet-irradiated cercariae | Q38967804 | ||
Waterborne infectious diseases--could they be consigned to history? | Q39002261 | ||
Spectrum of disease and relation to place of exposure among ill returned travelers | Q39011352 | ||
Comparative immunology of human and animal models of hookworm infection | Q39013774 | ||
Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma-secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylanicum | Q39030027 | ||
Immunization of baboons with attenuated schistosomula of Schistosoma haematobium: levels of protection induced by immunization with larvae irradiated with 20 and 60 krad | Q39051086 | ||
Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania | Q39056535 | ||
Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases | Q39078371 | ||
Neglected tropical disease vaccines | Q39078374 | ||
Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. | Q39096377 | ||
Turning neglected tropical diseases into forgotten maladies | Q39283920 | ||
Seroepidemiology of amebiasis in Mexico | Q39400427 | ||
Schistosoma mansoni and S. japonicum: comparison of levels of ultraviolet irradiation for vaccination of mice with cercariae | Q39414309 | ||
Seroepidemiology of Entamoeba histolytica in a slum in northeastern Brazil | Q39440061 | ||
Immunologic control of a parasitic arthropod. Identification of a protective antigen from Boophilus microplus | Q39594559 | ||
Seeking the ghost of worms past | Q39602856 | ||
Patterns in parasite epidemiology: the peak shift | Q39602864 | ||
Problems in comprehension of informed consent in rural and peri-urban Mali, West Africa | Q39764809 | ||
Industrial Development and Field Use of the Canine Hookworm Vaccine | Q39781740 | ||
Vaccination Against the Canine Hookworm Diseases | Q39998776 | ||
Hydatidosis/Cysticercosis: Immune Mechanisms and Immunization Against Infection | Q40106005 | ||
The present and future of vaccination for cutaneous leishmaniasis | Q40301328 | ||
Present and future control of cryptosporidiosis in humans and animals. | Q40460370 | ||
The global burden of intestinal nematode infections--fifty years on. | Q40493441 | ||
Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in China | Q40498833 | ||
T-cell and cytokine responses in leishmaniasis | Q40769758 | ||
Studies on immune responses to larval cestodes in mice. Increased susceptibility of certain mouse strains and hypothymic mice to Taenia taeniaeformis and analysis of passive transfer of resistance with serum | Q40807797 | ||
A single gene change can extend yeast life span: the role of Ras in cellular senescence | Q40844195 | ||
Proteolytic degradation of hemoglobin in the intestine of the human hookworm Necator americanus | Q42162237 | ||
Cryptosporidium parvum glycoprotein gp40 localizes to the sporozoite surface by association with gp15. | Q42571297 | ||
The neglected tropical diseases and their devastating health and economic impact on the member nations of the Organisation of the Islamic Conference | Q42582156 | ||
Immunotherapy for drug-refractory mucosal leishmaniasis | Q42598910 | ||
Proteomic analysis of Schistosoma mansoni cercarial secretions | Q46951966 | ||
Identification and cDNA cloning of two novel low molecular weight host-protective antigens from Taenia ovis oncospheres | Q47337784 | ||
Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine. | Q47587014 | ||
Potency assay design for adjuvanted recombinant proteins as malaria vaccines | Q48030992 | ||
Vaccination against hydatidosis using a defined recombinant antigen | Q48060295 | ||
A 14-kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins | Q48226050 | ||
Puberty and Age-related Changes in Susceptibility to Schistosome Infection | Q48546049 | ||
Peace through vaccine diplomacy | Q48864638 | ||
Human anti-saliva immune response following experimental exposure to the visceral leishmaniasis vector, Lutzomyia longipalpis. | Q51970673 | ||
Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. | Q52461534 | ||
Disruption of antigenic variation is crucial for effective parasite vaccine. | Q52600029 | ||
Sand fly specificity of saliva-mediated protective immunity in Leishmania amazonensis-BALB/c mouse model. | Q52657137 | ||
The role of Product Development Partnerships in research and development for neglected diseases. | Q53173524 | ||
CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14KDA Schistosoma mansoni fatty acid-binding protein. | Q54048739 | ||
Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal Leishmaniasis refractory to antimony: A case report. | Q54311663 | ||
Immunization of rats against Schistosoma mansoni using irradiated cercariae, lung schistosomula and liver-stage worms. | Q54467337 | ||
Influence of Mouse Strain on Induction of Resistance with Irradiated Schistosoma mansoni Cercariae | Q54566432 | ||
Health Innovation Networks to Help Developing Countries Address Neglected Diseases | Q56420403 | ||
Amebiasis | Q56608181 | ||
Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis | Q57392736 | ||
Mass Spectrometric Analysis of theSchistosomamansoniTegumental Sub-proteome | Q57666293 | ||
IN VITRO ONCOSPHERE-KILLING ASSAYS TO DETERMINE IMMUNITY TO THE LARVAE OF TAENIA PISIFORMIS, TAENIA OVIS, TAENIA SAGINATA, AND TAENIA SOLIUM | Q57804912 | ||
Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep | Q57932625 | ||
Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children | Q57940118 | ||
Human African trypanosomiasis (sleeping sickness) | Q58842371 | ||
A Technique for studying the in vitro Effect of Serum on Activated Taeniid Hexacanth Embryos | Q58950915 | ||
Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis | Q59278433 | ||
Protection Against Cutaneous Leishmaniasis Resulting from Bites of Uninfected Sand Flies | Q60211990 | ||
Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN) | Q60227750 | ||
Purification and evaluation of the integral membrane protein H11 as a protective antigen against Haemonchus contortus | Q64215663 | ||
Immunization of Mice with Cobalt-60 Irradiated Schistosoma Mansoni Cercariae * | Q67271983 | ||
The immunological response of the rat to infection with Taenia taeniaeformis. V. Sequence of appearance of protective immunoglobulins and the mechanism of action of 7Sgamma2a antibodies | Q67349463 | ||
Resistance against Schistosoma mansoni induced by immunization of mice with cryopreserved schistosomula | Q67433061 | ||
Schistosoma mansoni: Vaccination of mice with highly X-irradiated cercariae | Q70793489 | ||
Echinococcus granulosus cysts: Early development in vitro in the presence of serum from infected sheep | Q70944418 | ||
Taenia taeniaeformis in mice: protective immunization with oncospheres and their products | Q71185192 | ||
A mechanism to account for mouse strain variation in resistance to the larval cestode, Taenia taeniaeformis | Q71212219 | ||
Amoebiasis | Q73216780 | ||
Reverse vaccinology | Q73514027 | ||
Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment | Q73668677 | ||
Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection | Q74844618 | ||
In the absence of IL-12, the induction of Th1-mediated protective immunity by the attenuated schistosome vaccine is impaired, revealing an alternative pathway with Th2-type characteristics | Q77353762 | ||
Comparison of the local immune response against Giardia lamblia cyst wall protein 2 induced by recombinant Lactococcus lactis and Streptococcus gordonii | Q79810793 | ||
Dracunculiasis eradication | Q81204823 | ||
Eradication of Taenia solium cysticercosis: a role for vaccination of pigs | Q84226549 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neglected tropical disease | Q929451 |
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 237-270 | |
P577 | publication date | 2011-01-01 | |
P1433 | published in | Immunological Reviews | Q15724582 |
P1476 | title | Vaccines to combat the neglected tropical diseases | |
P478 | volume | 239 |
Q30419953 | "Barriers" to child development and human potential: the case for including the "neglected enteric protozoa" (NEP) and other enteropathy-associated pathogens in the NTDs |
Q35881296 | A history of hookworm vaccine development |
Q90053374 | A multi-method and structure-based in silico vaccine designing against Echinococcus granulosus through investigating enolase protein |
Q36702606 | A new model of progressive visceral leishmaniasis in hamsters by natural transmission via bites of vector sand flies |
Q54963598 | A novel B- and helper T-cell epitopes-based prophylactic vaccine against Echinococcus granulosus. |
Q21562256 | A research agenda for helminth diseases of humans: Intervention for control and elimination |
Q36278451 | Advances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccine |
Q34431558 | Age-related patterns in human myeloid dendritic cell populations in people exposed to Schistosoma haematobium infection |
Q56909277 | Antibody Responses to Schistosoma mansoni Schistosomula Antigens |
Q38953757 | Antibody trapping: A novel mechanism of parasite immune evasion by the trematode Echinostoma caproni. |
Q34152140 | Assessment of cathepsin D and L-like proteinases of poultry red mite, Dermanyssus gallinae (De Geer), as potential vaccine antigens |
Q43946809 | Characterization of Trichuris trichiura from humans and T. suis from pigs in China using internal transcribed spacers of nuclear ribosomal DNA. |
Q24187049 | Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas |
Q34171802 | Clear genetic distinctiveness between human- and pig-derived Trichuris based on analyses of mitochondrial datasets |
Q27321230 | Concerted activity of IgG1 antibodies and IL-4/IL-25-dependent effector cells trap helminth larvae in the tissues following vaccination with defined secreted antigens, providing sterile immunity to challenge infection |
Q28480978 | Cure of hookworm infection with a cysteine protease inhibitor |
Q35061244 | Design and synthesis of novel antileishmanial compounds |
Q35748586 | Distribution of Peripheral Memory T Follicular Helper Cells in Patients with Schistosomiasis Japonica |
Q21558510 | Ebola and Marburg hemorrhagic fevers: neglected tropical diseases? |
Q34297640 | Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment |
Q28541600 | Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen |
Q34030070 | Evaluation of an immunodot blot technique for the detection of antibodies against Taenia solium larval antigens |
Q33738522 | Evaluation of the Schistosoma mansoni Y-box-binding protein (SMYB1) potential as a vaccine candidate against schistosomiasis |
Q35989204 | Future Challenges for Vaccinologists |
Q28551644 | Generation of a Novel Bacteriophage Library Displaying scFv Antibody Fragments from the Natural Buffalo Host to Identify Antigens from Adult Schistosoma japonicum for Diagnostic Development |
Q26829956 | Helminth infections and host immune regulation |
Q26863301 | Helminth parasite proteomics: from experimental models to human infections |
Q37308692 | High prevalence of cysticercosis in people with epilepsy in southern Rwanda |
Q47775690 | Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice |
Q39078215 | Human anthelminthic vaccines: Rationale and challenges |
Q36288318 | Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted leishmania conferring ulcer-free protection |
Q38243220 | Immunity to visceral leishmaniasis: implications for immunotherapy |
Q27305577 | Immunization with L. sigmodontis microfilariae reduces peripheral microfilaraemia after challenge infection by inhibition of filarial embryogenesis |
Q36942712 | Immunological consequences of antihelminthic treatment in preschool children exposed to urogenital schistosome infection |
Q38261957 | Immunology of experimental and natural human hookworm infection |
Q64100250 | In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases |
Q41857121 | Infection and treatment immunizations for successful parasite vaccines |
Q34782668 | Ion channels and drug transporters as targets for anthelmintics |
Q36415941 | Mitigating an undesirable immune response of inherent susceptibility to cutaneous leishmaniosis in a mouse model: the role of the pathoantigenic HISA70 DNA vaccine |
Q34577243 | Mitochondrial genome of the eyeworm, Thelazia callipaeda (Nematoda: Spirurida), as the first representative from the family Thelaziidae |
Q38116117 | Nothing is perfect! Trouble-shooting in immunological and molecular studies of cestode infections |
Q45306485 | Patenting and the gender gap: should women be encouraged to patent more? |
Q37428688 | Pharmacokinetics of the Antischistosomal Lead Ozonide OZ418 in Uninfected Mice Determined by Liquid Chromatography-Tandem Mass Spectrometry |
Q35827541 | Pilot Field Trial of the EG95 Vaccine Against Ovine Cystic Echinococcosis in Rio Negro, Argentina: Second Study of Impact |
Q38121856 | Plant-derived pharmaceuticals for the developing world |
Q24635389 | Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic |
Q34510660 | Prevention and control of schistosomiasis: a current perspective |
Q36057144 | Proportions of CD4+ memory T cells are altered in individuals chronically infected with Schistosoma haematobium |
Q24203747 | Rapid screening and diagnostic tests for human schistosomiasis in endemic areas |
Q36368518 | Role of antibody dependent cell mediated cytotoxicity (ADCC) in Sm-p80-mediated protection against Schistosoma mansoni |
Q38162845 | Role of gap junctions and hemichannels in parasitic infections. |
Q24598949 | Schistosomiasis vaccines |
Q34961760 | Secretion of protective antigens by tissue-stage nematode larvae revealed by proteomic analysis and vaccination-induced sterile immunity. |
Q28541191 | Serological screening of the Schistosoma mansoni adult worm proteome |
Q40703480 | Serology and longevity of immunity against Echinococcus granulosus in sheep and llama induced by an oil-based EG95 vaccine |
Q89983540 | Serum proteomics of active tuberculosis patients and contacts reveals unique processes activated during Mycobacterium tuberculosis infection |
Q39014289 | Sm-p80-Based Schistosomiasis Vaccine: Preparation for Human Clinical Trials |
Q36256373 | Still hope for schistosomiasis vaccine |
Q35213518 | Structure and function of a "yellow" protein from saliva of the sand fly Lutzomyia longipalpis that confers protective immunity against Leishmania major infection |
Q50961497 | Successful immunization against a parasitic nematode by vaccination with recombinant proteins. |
Q47984552 | Synthesis of primaquine glyco-conjugates as potential tissue schizontocidal antimalarial agents. |
Q36692301 | THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL. |
Q38250382 | The Impact of Nurses on Neglected Tropical Disease Management |
Q50869625 | The Use of Reverse Vaccinology and Molecular Modeling Associated with Cell Proliferation Stimulation Approach to Select Promiscuous Epitopes from Schistosoma mansoni. |
Q38185911 | The future for vaccine development against Entamoeba histolytica |
Q45156525 | The mucosal response of hamsters exposed to weekly repeated infections with the hookworm Ancylostoma ceylanicum |
Q37147622 | The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas |
Q47294803 | The self-curing phenomenon of schistosome infection in rhesus macaques: insight from in vitro studies |
Q36550981 | Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases |
Q34600718 | UCP2 deficiency helps to restrict the pathogenesis of experimental cutaneous and visceral leishmaniosis in mice |
Q38194247 | Vaccination against helminth parasite infections. |
Q34700649 | Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infection |
Q26824128 | Vaccines for low-income countries |